We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

168 hedge funds and large institutions have $717M invested in Emergent Biosolutions in 2014 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 57 increasing their positions, 50 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

450% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 8

27% more funds holding

Funds holding: 132 → 168 (+36)

26% more capital invested

Capital invested by funds: $570M → $717M (+$148M)

14% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 50

9.04% more ownership

Funds ownership: 69.27% → 78.3% (+9%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
168
Holders Change
+36
Holders Change %
+27.27%
% of All Funds
4.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
44
Increased
57
Reduced
50
Closed
8
Calls
$319K
Puts
–
Net Calls
+$319K
Net Calls Change
-$278K

Top Buyers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
+$18.5M
2
NI
Numeric Investors
Massachusetts
+$10.7M
3
State Street
State Street
Massachusetts
+$10.7M
4
GT
Glenmede Trust
Pennsylvania
+$10.5M
5
GAM
Gotham Asset Management
New York
+$6.54M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$25.1M
2
SCA
SAC Capital Advisors
Connecticut
-$12.9M
3
KCM
Kingdon Capital Management
New York
-$7.3M
4
BA
BlackRock Advisors
Delaware
-$4.75M
5
AI
Ariel Investments
Illinois
-$2.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
51
BlackRock Advisors
Delaware
$2.83M -$4.75M -188,152 -63%
BIM
52
BlackRock Investment Management
Delaware
$2.7M +$32.8K +1,299 +1%
NAP
53
New Amsterdam Partners
New York
$2.67M +$2.67M +105,634 New
CS
54
Credit Suisse
Switzerland
$2.63M +$204K +8,063 +8%
Deutsche Bank
55
Deutsche Bank
Germany
$2.53M +$105K +4,158 +4%
GC
56
Globeflex Capital
California
$2.47M +$796K +31,520 +48%
Citadel Advisors
57
Citadel Advisors
Florida
$2.42M +$1.18M +46,836 +96%
PPA
58
Parametric Portfolio Associates
Washington
$2.37M +$362K +14,319 +18%
CCMH
59
Cornerstone Capital Management Holdings
New York
$2.29M -$1.78M -70,577 -44%
ZIM
60
Zacks Investment Management
Illinois
$2.02M +$2.01M +79,746 New
Barclays
61
Barclays
United Kingdom
$1.99M +$1.9M +75,249 +1,815%
ERSOT
62
Employees Retirement System of Texas
Texas
$1.97M -$935K -37,000 -32%
IG
63
ING Group
Netherlands
$1.92M – – –
VOYA Investment Management
64
VOYA Investment Management
Georgia
$1.86M +$740K +29,294 +66%
OAM
65
Oxford Asset Management
United Kingdom
$1.85M -$803K -31,784 -30%
NFA
66
Nationwide Fund Advisors
Ohio
$1.83M +$1.07M +42,400 +141%
MCM
67
Matarin Capital Management
New York
$1.8M -$137K -5,421 -7%
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$1.73M – – –
GCP
69
GSA Capital Partners
United Kingdom
$1.65M +$98.5K +3,900 +6%
IA
70
Icon Advisers
Colorado
$1.61M +$1.61M +63,700 New
First Trust Advisors
71
First Trust Advisors
Illinois
$1.59M +$397K +15,733 +33%
California Public Employees Retirement System
72
California Public Employees Retirement System
California
$1.58M – – –
Connor, Clark & Lunn Investment Management (CC&L)
73
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.51M +$604K +23,900 +79%
Public Sector Pension Investment Board (PSP Investments)
74
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.48M -$285K -11,300 -16%
SCP
75
Seizert Capital Partners
Michigan
$1.39M +$115K +4,547 +9%
1 2
3
4 5

EBS Hedge Fund Activity: Q1 2014 in Review

168 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q1 2014, worth a combined $717M — up 26% from $570M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new EBS positions and 8 closed out — a net gain of 36 holders — while 57 added to existing stakes and 50 trimmed.

The largest buyer was Broadfin Capital, adding an estimated $18.5M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $25.1M sold.

  • 168 institutional investors held Emergent Biosolutions (EBS) as of Q1 2014, up from 132 in Q4 2013.
  • Funds reported $717M of Emergent Biosolutions stock for Q1 2014, up 26% quarter-over-quarter.
  • 44 funds opened new Emergent Biosolutions positions in Q1 2014 and 8 closed out, a net change of +36 holders.
  • The largest Emergent Biosolutions buyer in Q1 2014 was Broadfin Capital, an estimated $18.5M added.
  • The largest Emergent Biosolutions seller in Q1 2014 was Consonance Capital Management, an estimated $25.1M sold.

Based on aggregated 13F filings for Q1 2014.